|
Real-time Estimate
Cboe BZX
14:12:22 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 42.24 USD | +0.58% |
|
+2.00% | -14.85% |
| 09-17 | Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger | MT |
| 08-03 | Supernus Pharmaceuticals, Inc. Revises Earnings Guidance for the Full Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.44B | - | - | - | ||
| 362B | |||||
| 64.74B | |||||
| 12.76B | |||||
| 7.53B | |||||
| 4.38B |
Select your edition
All financial news and data tailored to specific country editions
